Addex Therapeutics Ownership
| ADXN Stock | USD 0.36 0.01 2.70% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Addex |
Addex Stock Ownership Analysis
About 50.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.41. Some equities with similar Price to Book (P/B) outperform the market in the long run. Addex Therapeutics recorded a loss per share of 1.31. The entity had not issued any dividends in recent years. Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system disorders in Switzerland. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland. Addex Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people. For more info on Addex Therapeutics please contact Timothy Dyer at 41 22 884 1555 or go to https://www.addextherapeutics.com.Addex Therapeutics SEC Filings
SEC filings are important regulatory documents required of all public companies to provide to potential investors. Addex Therapeutics prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Addex Therapeutics investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Addex Therapeutics specific information freely available to individual and institutional investors to make a timely investment decision.
| 5th of September 2023 Other Events | View | |
| 10th of April 2023 Unclassified Corporate Event | View |
Addex Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Addex Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Addex Therapeutics backward and forwards among themselves. Addex Therapeutics' institutional investor refers to the entity that pools money to purchase Addex Therapeutics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Last Transaction | Type | Shares | Value | Nea Management Company Llc | 2023-06-30 | Common Shares | 180 K | 632.9 K | Armistice Capital Llc | 2023-06-30 | Common Shares | 264 K | 137.5 K | Endurant Capital Management Lp | 2023-03-31 | Common Shares | 120.7 K | 114.3 K | Old Mission Capital Llc 1 | 2023-03-31 | Common Shares | 65.7 K | 62.2 K | Virtu Financial Llc | 2023-03-31 | Common Shares | 42.9 K | 41 K | New Leaf Venture Partners Llc | 2022-09-30 | Common Shares | 50 K | 40 K | Citadel Advisors Llc | 2023-03-31 | Common Shares | 34.4 K | 32.5 K | Fny Investment Advisers Llc | 2022-09-30 | Common Shares | 22.5 K | 17 K | Millennium Management Llc | 2022-09-30 | Common Shares | 20 K | 16 K | Susquehanna International Group Llp | 2023-03-31 | Common Shares | 15.1 K | 14.3 K | Renaissance Technologies Llc | 2022-12-31 | Common Shares | 21.9 K | 14 K |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Addex Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Global Correlations Now
Global CorrelationsFind global opportunities by holding instruments from different markets |
| All Next | Launch Module |
Pair Trading with Addex Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Addex Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Addex Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Addex Stock
| + | 0.66 | KA | Kineta Inc | Fiscal Quarter End 30th of September 2023 | PairCorr | |
| + | 0.73 | ME | 23Andme Holding | Fiscal Quarter End 30th of September 2023 | PairCorr | |
| + | 0.82 | YS | YS Biopharma | Fiscal Quarter End 30th of September 2023 | PairCorr | |
| + | 0.64 | DMAC | DiaMedica Therapeutics | Fiscal Quarter End 30th of September 2023 | PairCorr |
Moving against Addex Stock
| - | 0.58 | GSK | GlaxoSmithKline PLC ADR | Fiscal Quarter End 30th of September 2023 | PairCorr | |
| - | 0.44 | VERA | Vera Therapeutics | Fiscal Quarter End 30th of September 2023 | PairCorr |
The ability to find closely correlated positions to Addex Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Addex Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Addex Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Addex Therapeutics to buy it.
The correlation of Addex Therapeutics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Addex Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Addex Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Addex Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Addex Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in banks. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for Addex Stock analysis
When running Addex Therapeutics' price analysis, check to measure Addex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Addex Therapeutics is operating at the current time. Most of Addex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Addex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Addex Therapeutics' price. Additionally, you may evaluate how the addition of Addex Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is Addex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.31) | Revenue Per Share 0.216 | Quarterly Revenue Growth 2.39 | Return On Assets (0.77) | Return On Equity (1.98) |
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.